Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension

Hypertens Res. 2011 Mar;34(3):404-6. doi: 10.1038/hr.2010.249. Epub 2010 Dec 16.

Authors

Jiro Suzuki, Fumio Otsuka, Kenichi Inagaki, Katsuyuki Tanabe, Naoko Tsukamoto, Tomoko Miyoshi, Eri Nakamura, Toshio Ogura, Isao Kumagai, Hirofumi Makino

PMID: 21160478
DOI: 10.1038/hr.2010.249

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Amlodipine / therapeutic use
Antihypertensive Agents / therapeutic use
Dihydropyridines / therapeutic use
Eplerenone
Humans
Hypertension, Renovascular / diagnostic imaging
Hypertension, Renovascular / drug therapy*
Male
Middle Aged
Mineralocorticoid Receptor Antagonists / therapeutic use*
Nephrotic Syndrome / diagnostic imaging
Nephrotic Syndrome / drug therapy*
Proteinuria / drug therapy
Radiography
Spironolactone / analogs & derivatives*
Spironolactone / therapeutic use
Treatment Outcome

Substances

Antihypertensive Agents
Dihydropyridines
Mineralocorticoid Receptor Antagonists
Amlodipine
Spironolactone
benidipine
Eplerenone